Paper23933154
Genetics and epigenetics of sporadic thyroid cancer.
Vu-Phan D and 1 other. Mol Cell Endocrinol, 2014. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Genetics and epigenetics of sporadic thyroid cancer. Papers, record 23933154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23933154
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epigenesis, Genetic | Major topic |
| Thyroid Neoplasms | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Mutation | |
| Neoplasm Proteins |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01CA151842 | NCI NIH HHS | United States | R01CA151842 | PubMed and NIH | NIH RePORTER |
| R01CA166033 | NCI NIH HHS | United States | R01CA166033 | PubMed and NIH | NIH RePORTER |
| R01 CA151842 | NCI NIH HHS | United States | R01CA151842 | PubMed and NIH | NIH RePORTER |
| T32 GM007315 | NIGMS NIH HHS | United States | T32GM007315 | PubMed and NIH | NIH RePORTER |
| R01 CA166033 | NCI NIH HHS | United States | R01CA166033 | PubMed and NIH | NIH RePORTER |
References227
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19356676 | Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E). | Biochim Biophys Acta | 2009 | https://conductscience.org/library/papers/19356676 | PubMed |
| 2 | 19773371 | Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. | Eur J Endocrinol | 2009 | https://conductscience.org/library/papers/19773371 | PubMed |
| 3 | 21952241 | Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma. | Endocrinology | 2011 | https://conductscience.org/library/papers/21952241 | PubMed |
| 4 | 16013975 | Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow. | Expert Rev Mol Diagn | 2005 | https://conductscience.org/library/papers/16013975 | PubMed |
| 5 | 12697856 | BRAF mutation in papillary thyroid carcinoma. | J Natl Cancer Inst | 2003 | https://conductscience.org/library/papers/12697856 | PubMed |
| 6 | 22239435 | Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils. | Expert Opin Ther Targets | 2012 | https://conductscience.org/library/papers/22239435 | PubMed |
| 7 | 21512141 | Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse. | Cancer Res | 2011 | https://conductscience.org/library/papers/21512141 | PubMed |
| 8 | 21050834 | An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene. | Cancer Epidemiol | 2011 | https://conductscience.org/library/papers/21050834 | PubMed |
| 9 | 14602780 | BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. | J Clin Endocrinol Metab | 2003 | https://conductscience.org/library/papers/14602780 | PubMed |
| 10 | 11889175 | Functionally impaired TR mutants are present in thyroid papillary cancer. | J Clin Endocrinol Metab | 2002 | https://conductscience.org/library/papers/11889175 | PubMed |
| 11 | 8552381 | Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. | Oncogene | 1996 | https://conductscience.org/library/papers/8552381 | PubMed |
| 12 | 7985080 | N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. | Surgery | 1994 | https://conductscience.org/library/papers/7985080 | PubMed |
| 13 | 19837916 | RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. | J Clin Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19837916 | PubMed |
| 14 | 7565764 | The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7565764 | PubMed |
| 15 | 19506552 | Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas. | Lab Invest | 2009 | https://conductscience.org/library/papers/19506552 | PubMed |
| 16 | 1890154 | Ras oncogene mutations in benign and malignant thyroid neoplasms. | J Clin Endocrinol Metab | 1991 | https://conductscience.org/library/papers/1890154 | PubMed |
| 17 | 11237210 | Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. | Recent Prog Horm Res | 2001 | https://conductscience.org/library/papers/11237210 | PubMed |
| 18 | 20473860 | Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20473860 | PubMed |
| 19 | 21934341 | Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. | Onkologie | 2011 | https://conductscience.org/library/papers/21934341 | PubMed |
| 20 | 22793259 | Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib. | Thyroid | 2012 | https://conductscience.org/library/papers/22793259 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42210541 | An Integrated Approach Combining Chemical Profiling, Network Pharmacology, and Experimental Validation Is Used to Clarify the Pharmacological Basis of the Yiqi-Tongluo-Huoxue-Mingmu Formula in Diabetic Retinopathy. | J Diabetes Res | 2026 | https://conductscience.org/library/papers/42210541 | PubMed |
| 41595702 | State of the Art on Thyroid Cancer Biology and Oncology. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595702 | PubMed |
| 40722658 | Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients' Selection. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722658 | PubMed |
| 39252309 | Construction of thyroid cancer classification and iodine metabolism related diagnostic model using thyroid differentiation score and bioinformation. | Medicine (Baltimore) | 2024 | https://conductscience.org/library/papers/39252309 | PubMed |
| 39061714 | Liquid Biopsies in Follicular Thyroid Carcinomas-A Brief Report. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39061714 | PubMed |
| 37898857 | Association of Promoter Methylation Patterns with Expression of MAPK14 in Tissue of Papillary Thyroid Cancer Patients. | Asian Pac J Cancer Prev | 2023 | https://conductscience.org/library/papers/37898857 | PubMed |
| 37046817 | The Role of Exosomes in Epithelial-to-Mesenchymal Transition and Cell Functional Properties in Head and Neck Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37046817 | PubMed |
| 35846375 | Targeting Autophagy in Thyroid Cancer: EMT, Apoptosis, and Cancer Stem Cells. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35846375 | PubMed |
| 34335811 | Study on the Antitumor Effect and Glycolysis of Andrographolide in Anaplastic Thyroid Carcinoma. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34335811 | PubMed |
| 33916320 | Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies. | J Clin Med | 2021 | https://conductscience.org/library/papers/33916320 | PubMed |
| 33915745 | Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals. | Healthcare (Basel) | 2021 | https://conductscience.org/library/papers/33915745 | PubMed |
| 33633989 | Evaluation of the diagnostic performance of contrast-enhanced ultrasound combined with BRAF V600E gene detection in nodules of unclear significance by thyroid fine-needle aspiration. | Gland Surg | 2021 | https://conductscience.org/library/papers/33633989 | PubMed |
| 33519470 | MOF Regulates TNK2 Transcription Expression to Promote Cell Proliferation in Thyroid Cancer. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33519470 | PubMed |
| 32982967 | Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32982967 | PubMed |
| 32593310 | BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features. | World J Surg Oncol | 2020 | https://conductscience.org/library/papers/32593310 | PubMed |
| 32072403 | Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas. | Mol Biol Rep | 2020 | https://conductscience.org/library/papers/32072403 | PubMed |
| 31502714 | Genome-wide association study of circulating folate one-carbon metabolites. | Genet Epidemiol | 2019 | https://conductscience.org/library/papers/31502714 | PubMed |
| 31378850 | Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review. | Endocrine | 2019 | https://conductscience.org/library/papers/31378850 | PubMed |
| 31293659 | Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma. | J Cancer | 2019 | https://conductscience.org/library/papers/31293659 | PubMed |
| 30107176 | Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. | Cancer Cell | 2018 | https://conductscience.org/library/papers/30107176 | PubMed |
Genes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23933154
GET https://conductscience.org/api/papers/v1/23933154/references?page=2